Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure
Open Access
- 31 March 1997
- Vol. 49 (3), 23-30
- https://doi.org/10.1016/s0090-4295(97)00165-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy gleason score in prediction of final pathologic diagnosis in prostate cancerUrology, 1995
- A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate CancerJournal of Urology, 1995
- A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable psa after radical prostatectomyUrology, 1994
- Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assayUrology, 1994
- Current role of MR imaging in the staging of adenocarcinoma of the prostate.Radiology, 1993
- Prostate: MR imaging with an endorectal surface coil.Radiology, 1989
- Patient Survival and Local Recurrence Rate Following Radical Prostatectomy for Prostatic CarcinomaJournal of Urology, 1986
- Definitive radiotherapy following prostatectomy: Results and complicationsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958